Vins Bioproducts Limited — Serum Exporter Profile
Indian Pharmaceutical Exporter · #2 for Serum · $6.0M export value · DGFT Verified
Vins Bioproducts Limited is the #2 Indian exporter of Serum with $6.0M in export value and 132 verified shipments. Vins Bioproducts Limited holds a 21.1% market share in Serum exports across 34 countries. The company exports 3 pharmaceutical products worth $15.7M across 1 therapeutic categories.
Vins Bioproducts Limited — Serum Export Profile: Buyers & Destinations
Where Does Vins Bioproducts Limited Export Serum?
| Country | Value | Shipments | Share |
|---|---|---|---|
| THAILAND | $932.8K | 20 | 19.1% |
| PHILIPPINES | $827.2K | 34 | 17.0% |
| SRI LANKA | $363.4K | 9 | 7.4% |
| ANGOLA | $258.2K | 7 | 5.3% |
| SUDAN | $195.7K | 4 | 4.0% |
| GHANA | $192.9K | 13 | 4.0% |
| KENYA | $166.3K | 7 | 3.4% |
| MYANMAR | $163.5K | 4 | 3.4% |
| GEORGIA | $150.0K | 3 | 3.1% |
| COTE D IVOIRE | $126.4K | 4 | 2.6% |
Vins Bioproducts Limited exports Serum to 43 countries. The largest destination is THAILAND accounting for 19.1% of Vins Bioproducts Limited's Serum shipments, followed by PHILIPPINES (17.0%) and SRI LANKA (7.4%). These destinations reflect Vins Bioproducts Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Serum from Vins Bioproducts Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CUST ID: BILTP | PHILIPPINES | $400.0K | 8 |
| DLCNB | THAILAND | $350.0K | 7 |
| CUST ID:DLCNB | THAILAND | $200.0K | 4 |
| SCPSC | SRI LANKA | $150.0K | 3 |
| CUST ID:BILTP | PHILIPPINES | $150.0K | 3 |
| GOVERNMENT OF ANGOLA MINISTRY OF HE | ANGOLA | $150.0K | 3 |
| CUST ID:SCPSC | SRI LANKA | $123.4K | 4 |
| IBNSINA PHARMA | EGYPT | $119.0K | 3 |
| GOVERNMENT OF ANGOLA/MINISTRY OF HE | ANGOLA | $103.2K | 3 |
| BILTP | PHILIPPINES | $100.0K | 2 |
Vins Bioproducts Limited supplies Serum to 125 buyers globally. The largest buyer is CUST ID: BILTP (PHILIPPINES), followed by DLCNB (THAILAND) and CUST ID:DLCNB (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Serum Export Value and How Much Does Vins Bioproducts Limited Contribute?
India exported $18.4M worth of Serum through 15,000 shipments from 341 suppliers to 122 countries, serving 897 buyers globally. Vins Bioproducts Limited contributes $6.0M to this total, accounting for 21.1% of India's Serum exports. Vins Bioproducts Limited ships Serum to 43 countries through 125 buyers.
What Is the Average Shipment Value for Vins Bioproducts Limited's Serum Exports?
Vins Bioproducts Limited's average Serum shipment value is $45.3K per consignment, based on 132 shipments totaling $6.0M. The largest destination is THAILAND (19.1% of Vins Bioproducts Limited's Serum exports).
How Does Vins Bioproducts Limited Compare to Other Indian Serum Exporters?
Vins Bioproducts Limited ranks #2 among 341 Indian Serum exporters with a 21.1% market share. The top 3 exporters are BHARAT SERUMS AND VACCINES LIMITED ($6.5M), VINS BIOPRODUCTS LIMITED ($5.7M), PREMIUM SERUMS AND VACCINES PRIVATE LIMITED ($1.4M). Vins Bioproducts Limited processed 132 shipments to 34 destination countries.
What Serum Formulations Does Vins Bioproducts Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| RABIES ANTISERUM 1000 IU (VINRAB 1000 IU | $232.9K | 11 |
| SNAKE VENOM ANTISERUM IP LYOPHILISED | $155.4K | 5 |
| RABIES ANTISERUM (VINRAB 1000 IU) (56 VAILS FREE OF COST)VLS | $150.0K | 3 |
| RABIES ANTISERUM (VINRAB 1000 IU) (128 VAILS FREE OF COST)VLS | $150.0K | 3 |
| RABIES ANTISERUM (VINRAB 1000 IU) (UNIT5 ML) (QTY FOC 12 VLS)VLS | $150.0K | 3 |
| SNAKE VENOM ANTISERUM I H S LYOPHILISED AFRIVEN | $150.0K | 3 |
| SNAKE VENOM ANTISERUM (AFRICAN) LYOPHILI | $107.9K | 6 |
| SCORPION VENOM ANTISERUM LYOPHILISED | $100.2K | 3 |
| RABIES ANTISERUM 1000IU(VINRAB 1000IU)LI | $100.0K | 2 |
| SNAKE VENOM ANTISERUM(AFRICAN) LYOPHILISED (AFRIVEN)VLS | $100.0K | 2 |
Vins Bioproducts Limited exports 163 distinct Serum formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RABIES ANTISERUM 1000 IU (VINRAB 1000 IU with 11 shipments worth $232.9K.
How Does Vins Bioproducts Limited Compare to Nearest Serum Exporters?
Exporters ranked immediately above and below #2 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | BHARAT SERUMS AND VACCINES LIMITED | $6.5M | 131 | 29 | $50.0K |
| 2 | VINS BIOPRODUCTS LIMITED ★ | $5.7M | 132 | 34 | $43.3K |
| 3 | PREMIUM SERUMS AND VACCINES PRIVATE LIMITED | $1.4M | 31 | 21 | $46.5K |
| 5 | ADVY CHEMICAL PRIVATE LIMITED | $1.1M | 253 | 15 | $4.5K |
Vins Bioproducts Limited ranks #2 among 341 Indian Serum exporters. Average shipment value of $43.3K compared to the market average of $54.1K. The closest competitors by value are BHARAT SERUMS AND VACCINES LIMITED and PREMIUM SERUMS AND VACCINES PRIVATE LIMITED.
Which Indian Ports Ship Serum Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 3,759 | 25.1% |
| SAHAR AIR | 2,925 | 19.5% |
| DELHI AIR | 2,682 | 17.9% |
| DELHI AIR CARGO ACC (INDEL4) | 1,589 | 10.6% |
| Bombay Air | 1,099 | 7.3% |
| Delhi Air | 546 | 3.6% |
| NHAVA SHEVA SEA (INNSA1) | 208 | 1.4% |
| HYDERABAD ACC (INHYD4) | 118 | 0.8% |
What Other Other Products Does Vins Bioproducts Limited Export?
Vins Bioproducts Limited also exports these other products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Vins Bioproducts Limited's Serum Exports
Recent geopolitical developments have introduced significant challenges for Indian pharmaceutical exporters like Vins Bioproducts. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight costs and extended delivery times. These disruptions are particularly impactful for time-sensitive biologic products, where delays can compromise product efficacy. (pharmaceuticalcommerce.com)
In the United States, the imposition of tariffs on pharmaceutical imports has created an uncertain trade environment. Although generic drugs have been exempted from these tariffs as of October 2025, the initial imposition had already caused market volatility and necessitated strategic adjustments by exporters. (medboundtimes.com)
The European Union's stringent regulatory frameworks, including the Falsified Medicines Directive, demand rigorous compliance from exporters. For Vins Bioproducts, maintaining adherence to these evolving standards is crucial to sustaining and expanding its market presence in Europe.
Vins Bioproducts Limited — Regulatory Compliance & Quality Standards
The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the US FDA intensifying inspections to ensure compliance with Good Manufacturing Practices (GMP). For Indian exporters, including Vins Bioproducts, this necessitates continuous investment in quality systems and infrastructure to meet international standards. (fact.net.in)
Vins Bioproducts' commitment to quality is evident in its state-of-the-art manufacturing facilities and adherence to international norms. This dedication not only facilitates access to regulated markets but also enhances the company's reputation as a reliable supplier of critical biologic therapies.
About Vins Bioproducts Limited
Vins Bioproducts Limited exports 3 products worth $15.7M. Beyond Serum, top products include Antitoxin, Immunoglobulin. View the complete Vins Bioproducts Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Serum — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Serum shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Vins Bioproducts Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 236 individual customs records matching Vins Bioproducts Limited exporting Serum, covering 163 formulations to 43 countries via 125 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 122+ countries, 897+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Serum Export Data from Vins Bioproducts Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Vins Bioproducts Limited's Serum exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Vins Bioproducts Limited
Full Company Profile →
3 products · $15.7M total trade · 1 categories
Serum Stats
Company Overview
Top Products by Vins Bioproducts Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Vins Bioproducts Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Serum. For current shipment-level data, contact TransData Nexus.